Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketoconazole, Mitoxantrone, and GM-CSF in HRPC
NCT00447473Phase 2Terminated
- Sponsor
- Houston Methodist Research Institute
- Start
- Jul 2006
- Primary completion
- Aug 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of sargramostim in prostate cancer (PCa), sponsored by Houston Methodist Research Institute. Started Jul 2006; status: terminated.
02
Drugs
sargramostim
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00447473.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00447473.